Women who conceive again within 6 months of a miscarriage have better odds of a successful second pregnancy than women who wait longer, according to a retrospective, population-based study from the United Kingdom.
Women who conceive again within 6 months of a miscarriage have better odds of a successful second pregnancy than women who wait longer, according to a retrospective, population-based study from the United Kingdom of almost 31,000 women. Women who became pregnant again within 6 months were less likely to have another miscarriage (adjusted OR, 0.66; 95% CI, 0.57-0.77), to terminate the pregnancy (adjusted OR, 0.43; 95% CI, 0.33-0.57), or to have an ectopic pregnancy (adjusted OR, 0.48; 95% CI, 0.34-0.69) than those who waited 6 to 12 months. Those who waited more than 24 months were more than twice as likely to have a pregnancy termination (adjusted OR, 2.40; 95% CI, 1.91-3.01) or an ectopic pregnancy (adjusted OR, 1.97; 95% CI, 1.42-2.72). Women who conceived again within 6 months and had a live birth were also less likely to have a cesarean delivery (adjusted OR, 0.90; 95% CI, 0.83-0.98), preterm delivery (adjusted OR, 0.89; 95% CI, 0.81-0.98), or a low birth weight infant (adjusted OR, 0.84; 95% CI, 0.71-0.89) than those women who waited longer to attempt conception.
Love ER, Bhattachaya S, Smith NC, Bhattachaya S. Effect of interpregnancy interval on outcomes of pregnancy after miscarriage: retrospective analysis of hospital episode statistics in Scotland. BMJ. 2010;341:c3967.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More